Researchers have found a substitute for insulin to help treat diabetes orally, replacing painful pricks. Over 10 years, Erik Helmerhorst, professor at Curtin University, and colleagues looked at three million compounds on pharmaceutical databases to try to emulate the molecular map of insulin. They found one, and are developing it to 'take the needle out of diabetes'. "Our innovation is the development of a new chemical entity, a small drug molecule we have discovered and developed, that can be taken orally as a tablet to replace insulin per se," said Helmerhorst. The research has the ability to revolutionise the treatment of diabetes, which is a growing problem worldwide. Helmerhorst said there was a niche market for their drug molecule to target Type 2 diabetics to help delay the onset of insulin dependency, according to a Curtin statement. He said 95 percent of diabetics have Type 2 diabetes; they last year spent some $10 billion on insulin. "The reality is that nearly one-third of Type 2 diabetics will end up needing insulin therapy at some stage," he said. According to the scientist, the insulin substitute would appeal to people who were averse to taking insulin via injections or by pumps. Helmerhorst outlined his team's quest at the Univation 2011 conference in Perth Nov 2-3.
GMT 14:01 2018 Thursday ,30 August
Expat with rare heart disorder gets life-saving surgeryGMT 00:18 2018 Tuesday ,23 January
Boy with 10-pound tumour on face diesGMT 21:23 2018 Monday ,22 January
All set for first global medical tourism conference in DubaiGMT 22:46 2018 Sunday ,21 January
Second face transplant for FrenchmanGMT 07:51 2018 Saturday ,20 January
Trio aquitted of negligence in Canada railway disasterGMT 10:57 2018 Thursday ,18 January
Breastfeeding for 6 months cuts diabetes risk in half: studyGMT 16:10 2018 Wednesday ,17 January
Child mummy in Italy had hepatitis, not smallpoxGMT 18:36 2018 Tuesday ,16 January
Greece strikes cause transport chaos, healthcare delays

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor